Sorry but the conversions are not necessarily done, I do believe. The loan covenants specify that Mr. Fife's companies cannot hold more than 10% of the stock at any time, so when some debt comes due that VHUB can't pay with cash, there's a high interest rate accrued until Fife sells some of his existing shares - and then he can convert once again, and at a low price since his selling the pre-existing shares will have driven the stock price down. There's also a "true-up" provision in the loan covenants which means he gets more cheapies.
I am not totally certain that I have this completely right, but you will see in the 10K, if I'm remembering correctly, that some millions of true-up shares have been issued, which wss part of the explanation of how total issued shares grew to 90 million in the prior fiscal year.
Let's see what the quarterly 10Q filing tells us regarding whether issued shares grew beyond 90 million in the first quarter of the fiscal year...and let's also see how the loss (I'm guessing that there will be one) has been financed (I'm guessing that some of it will be via stretching out the accounts payable cycle).
All of this negativity aside, VHUB does remain a company on track for over $10 million in annual sales, with an improving regulatory climate due to the Trump election, and an increasing measure of foreign business which is less subject to FDA control...not even mentioning Cash's favorable technical analysis of the stock.
